Skip to main content

Closed

HBIO: Harvard Bioscience, Inc. Stock Analysis | finqOS

Healthcare · Medical - Instruments & Supplies

Loading chart data...

Current StateBalance holding

The verdict

Good business

Mixed

Revenue growth-8.1% / yr

Operating margin1.4%

ROIC2.1%

Financially safe

Stretched

Debt / equity4.39×

Interest coverage0.5×

Current ratio1.99×

Harvard Bioscience, Inc.

HBIONASDAQ·USD·Closed

Harvard Bioscience, Inc.

HBIONASDAQ·USD·Closed

$6.10

+0.16%

$6.10

+$0.01 (0.16%)

52W Range

41thpctl

Volume

0.97×avg

Mkt Cap

27.51MUSD

P/E

-2.8TTM

Div Yield

–ann

52W Range

41thpctl

Volume

0.97×avg

Market Cap

27.51MUSD

P/E Ratio

-2.8TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings